160 related articles for article (PubMed ID: 7750028)
1. Elongation of the side chain of analogs of 1 alpha,25-dihydroxyvitamin D3 prevents osteopenia in a rat model.
Harada M; Takamura T; Kajita-Kondo S; Kozakai A; Miyahara T; Kozuka H; Ikekawa N; Higuchi S; Otomo S
Calcif Tissue Int; 1995 Mar; 56(3):220-6. PubMed ID: 7750028
[TBL] [Abstract][Full Text] [Related]
2. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
[TBL] [Abstract][Full Text] [Related]
3. Calcium regulating activity of 26,27-dialkyl analogs of 1 alpha,25-dihydroxyvitamin D3.
Miyahara T; Harada M; Miyata M; Sugure A; Ikemoto Y; Takamura T; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Calcif Tissue Int; 1992 Sep; 51(3):218-22. PubMed ID: 1330237
[TBL] [Abstract][Full Text] [Related]
4. 26,27-Hexafluoro-1,25-dihydroxyvitamin D3 (F6-1,25(OH)2D3) prevents osteoporosis induced by immobilization combined with ovariectomy in the rat.
Okumura H; Yamamuro T; Higuchi S; Harada M; Takamura T; Otomo S; Aihara H; Ikekawa N; Kobayashi T
Bone Miner; 1990 May; 9(2):101-9. PubMed ID: 2350614
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.
Erben RG; Weiser H; Sinowatz F; Rambeck WA; Zucker H
Calcif Tissue Int; 1992 Mar; 50(3):228-36. PubMed ID: 1617497
[TBL] [Abstract][Full Text] [Related]
6. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies of vitamin D analogs. XXIV. Synthesis of active vitamin D3 analogs substituted at the 2 beta-position and their preventive effects on bone mineral loss in ovariectomized rats.
Ono Y; Watanabe H; Shiraishi A; Takeda S; Higuchi Y; Sato K; Tsugawa N; Okano T; Kobayashi T; Kubodera N
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1626-30. PubMed ID: 9353890
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
[TBL] [Abstract][Full Text] [Related]
11. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
[TBL] [Abstract][Full Text] [Related]
12. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3.
Gniadecki R; Serup J
Biochem Pharmacol; 1995 Mar; 49(5):621-4. PubMed ID: 7887976
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
[TBL] [Abstract][Full Text] [Related]
16. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats.
Matsumoto T; Ikeda K; Yamato H; Morita K; Ezawa I; Fukushima M; Nishii Y; Ogata E
Biochem J; 1988 Mar; 250(3):671-7. PubMed ID: 2839142
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
Erben RG; Bromm S; Stangassinger M
Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
[TBL] [Abstract][Full Text] [Related]
18. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
de Vos S; Holden S; Heber D; Elstner E; Binderup L; Uskokovic M; Rude B; Chen DL; Le J; Cho SK; Koeffler HP
Prostate; 1997 May; 31(2):77-83. PubMed ID: 9140119
[TBL] [Abstract][Full Text] [Related]
19. [Study on the correlations between the bone quality and level of u-DPD and serum 1,25-(OH)2D3 in the ovariectomized osteoporosis rats].
Lin YP; Guo SM; Wu YS; Lin Y; Lu TX; Huang MY; Huang YM
Zhongguo Gu Shang; 2008 Dec; 21(12):910-3. PubMed ID: 19146159
[TBL] [Abstract][Full Text] [Related]
20. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
